ALLMedicine™ Abdominal Abscess Center
Research & Reviews 412 results
https://doi.org/10.1007/s11605-023-05631-x
Journal of Gastrointestinal Surgery : Official Journal Of... Plietz MC, Coste M et. al.
Mar 14th, 2023 - The most common surgery for ulcerative colitis (UC) is the staged restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA). On occasion, an emergent first-stage subtotal colectomy must be performed. The purpose of this study was to com...
https://clinicaltrials.gov/ct2/show/NCT00194298
Mar 6th, 2023 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...
https://doi.org/10.1016/S2352-3026(22)00402-1
The Lancet. Haematology; Talboom K, Borstlap WAA et. al.
Mar 3rd, 2023 - A third of patients with colorectal cancer who are eligible for surgery in high-income countries have concomitant anaemia associated with adverse outcomes. We aimed to compare the efficacy of preoperative intravenous and oral iron supplementation ...
https://clinicaltrials.gov/ct2/show/NCT03441893
Mar 3rd, 2023 - The prospective cohort and randomized, double-blind, placebo controlled study will be conducted on the basis of Research Institute of Epidemiology, Microbiology and Infectious Diseases and Coloproctology department of the Republic clinical hospita...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947093
International Journal of Colorectal Disease; Oliveira A, Faria S et. al.
Feb 23rd, 2023 - Postoperative complications after a colonic and rectal surgery are of significant concern to the surgical community. Although there are different techniques to perform anastomosis (i.e., handsewn, stapled, or compression), there is still no consen...
Drugs 229 results see all →
Clinicaltrials.gov 44 results
https://clinicaltrials.gov/ct2/show/NCT00194298
Mar 6th, 2023 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...
https://clinicaltrials.gov/ct2/show/NCT03441893
Mar 3rd, 2023 - The prospective cohort and randomized, double-blind, placebo controlled study will be conducted on the basis of Research Institute of Epidemiology, Microbiology and Infectious Diseases and Coloproctology department of the Republic clinical hospita...
https://clinicaltrials.gov/ct2/show/NCT05705557
Jan 31st, 2023 - Over the last two decades, significant advances have been made in hepatectomy because of advancements in surgical techniques and improvement on parenchymal transection. Modern liver surgeon must be equipped with excellent theoretical and clinical ...
https://clinicaltrials.gov/ct2/show/NCT05687825
Jan 18th, 2023 - Pancreaticoduodenectomy (PD) procedure is one of the standard treatments for benign and malignant diseases of the periampullary region and head of the pancreas. However, PD is still technically challenging and has significant rates of morbidity (u...
https://clinicaltrials.gov/ct2/show/NCT04042259
Jan 11th, 2023 - Surgical site infection rates for contaminated or dirty laparotomy wounds can be as high as 45%. Surgical management of dirty and contaminated wounds has been controversial in the literature and between surgeons. Primary closure (PC) of these woun...
News 30 results
https://www.mdedge.com/hematology-oncology/article/258993/gastrointestinal-cancer/laparoscopic-gastrectomy-gastric-cancer
Oct 26th, 2022 - Key clinical point: Postoperative nonsteroidal anti-inflammatory drug (NSAID) use in intravenous patient-controlled analgesia (IV-PCA) is associated with an increased risk for anastomotic leakage, duodenal stump leakage, intra-abdominal bleeding,.
https://www.onclive.com/view/belzutifan-plus-cabozantinib-elicits-high-response-rate-in-treatment-na-ve-advanced-clear-cell-rcc
Sep 16th, 2022 - Belzutifan (Welireg) plus cabozantinib (Cabometyx) was well tolerated and demonstrated promising antitumor activity in patients with treatment-naïve advanced clear cell renal cell carcinoma (RCC), according to findings from cohort 1 of the phase 2...
https://www.onclive.com/view/second-line-rgx-202-01-plus-folfiri-bevacizumab-shows-early-efficacy-safety-in-kras-mutant-crc
Jun 29th, 2022 - A second-line combination regimen comprised of RGX-202-01, FOLFIRI (leucovorin, 5-fluouracil [5-FU], and irinotecan), and bevacizumab (Avastin) demonstrated an encouraging efficacy signal and a favorable toxicity profile in patients with KRAS-muta...
https://www.mdedge.com/gihepnews/article/242150/ibd-intestinal-disorders/encouraging-evidence-supports-tofacitinib-use
Jun 24th, 2021 - Key clinical point: Tofacitinib induced rapid clinical response with sustained efficacy in nearly half of the pediatric and young adults with medically refractory inflammatory bowel disease (IBD) with a safety profile similar to that in adults. Ma.
https://www.onclive.com/view/crizotinib-confirmed-as-standard-of-care-for-alk-inflammatory-myofibroblastic-tumors
Dec 20th, 2020 - Patrick Schöffski, MD, MPH Treatment with crizotinib (Xalkori) elicited an objective response rate (ORR) of 50% (95% CI, 21.1%-78.9%) for patients with ALK-positive advanced, inoperable inflammatory myofibroblastic tumor (IMT), according to findi...